News

Integrated Research Launches Prognosis 13.1 for Enhanced UC&C

Integrated Research Launches Prognosis 13.1 for Enhanced UC&C

A Breakthrough in UC&C Intelligence

Integrated Research (IR) (ASX:IRI), renowned for its expert observability solutions, has recently unveiled its latest creation, Prognosis 13.1. This new product marks an important moment for organizations seeking to enhance their unified communication and collaboration (UC&C) capabilities in an increasingly complex digital landscape.

Understanding the Need for Advanced UC&C Solutions

As businesses grow and evolve, the challenges of managing disparate communication systems and ensuring seamless collaboration become more pronounced. IR recognizes these challenges and has committed to delivering innovative solutions that empower clients to gain deeper insights into their IT environments, while remaining vendor-neutral.

Introducing New Product Features

Prognosis 13.1 brings a suite of powerful new features designed specifically to tackle the needs of large enterprises.

One of the most notable additions is the Cloud Migration Assurance, which offers tailored migration management tools for those transitioning to cloud-based collaboration systems. This feature helps businesses navigate the complexities of this shift with confidence.

The launch also includes Webex Dedicated Instance, which delivers a comprehensive set of observability tools optimized for the deployment of Webex in a private cloud environment. This addition enhances the visibility and performance of organizations using this popular collaboration tool.

Furthermore, IR has integrated Cisco IPv6 Support into Prognosis 13.1, ensuring compatibility with the latest Internet Protocol technology. This support is crucial as organizations increasingly adopt modern networking solutions.

Lastly, the new Discovery tools offer enhanced dashboards and reporting capabilities that allow for extensive customization and insights, helping businesses make data-driven decisions.

Empowering Businesses for Success

Michael Tomkins, CTO at IR, emphasizes the significance of this release, stating, "Businesses need solutions that evolve with them, providing deeper insights, greater control, and long-term adaptability. This release sets a new standard for UC&C intelligence, equipping our clients with powerful and flexible analytics capabilities to drive success today and into the future." This commitment to innovation underscores IR's dedication to supporting its clients through ongoing development and enhancements.

The Road Ahead for Integrated Research

Prognosis 13.1 is just the beginning of an ambitious plan for IR. The company is set to continue its innovation-led program with further updates and new capabilities poised to meet the evolving needs of the marketplace.

To learn more about the features of Prognosis 13.1 and its impact on businesses, the company invites interested readers to visit their website for further details.

About Integrated Research

Integrated Research (IR) stands out as a premier provider of observability solutions for mission-critical IT infrastructure, payment processing, and communication ecosystems. The company’s flagship Prognosis platform equips organizations with the much-needed visibility and insights to optimize their critical technology performance. In doing so, IR helps enterprises enhance user experiences and drive sustainable growth through continuous innovation.

IR continues to be at the forefront of technological advancements, ensuring businesses can thrive in today’s fast-paced digital environment.

Frequently Asked Questions

What is Prognosis 13.1?

Prognosis 13.1 is the latest version of Integrated Research's observability platform, designed to enhance unified communication and collaboration for large enterprises.

What new features does Prognosis 13.1 include?

The new features include Cloud Migration Assurance, Webex Dedicated Instance, Cisco IPv6 Support, and advanced discovery tools for reporting and analysis.

How does Prognosis 13.1 help businesses?

It provides deeper insights, greater control, and robust analytics, allowing businesses to manage their communication systems more effectively.

Is Integrated Research focused on innovation?

Yes, IR is committed to ongoing innovation and development to meet the dynamic needs of its clients.

How can I learn more about Prognosis 13.1?

For more information, you can visit Integrated Research's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 3

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 3

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 5

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 1

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 2

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 3

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Diamonds Resilient Amid Market Shifts and Trends

Updated Category News Views 679

The Strength of Natural Diamonds in Today's Market As we enter a new year, the natural diamond market has shown a robust performance, providing encouraging signs of stability, strength, and growth. Jewelers have reported solid year-end results, showcasing steady or improved sales levels compared to previous periods. This positive trend reinforces the perception of natural...

Continue Reading
Bicara Therapeutics' Plans for Public Offering Showcase Growth

Updated Category News Views 183

Overview of Bicara Therapeutics' Initial Public Offering Bicara Therapeutics Inc. (NASDAQ: BCAX), an innovative biopharmaceutical company currently in the clinical stage, has just taken an exciting step forward. They've announced the pricing for their initial public offering (IPO), which includes 17,500,000 shares of common stock, each priced at a competitive $18.00. This...

Continue Reading
Class Action Alert for Semtech Corporation Investors

Updated Category News Views 107

Legal Update for Semtech Corporation Shareholders The Gross Law Firm has released an important notice specifically for shareholders of Semtech Corporation (NASDAQ: SMTC). This notice comes in light of a class action lawsuit that has been filed, and it outlines essential details regarding the lawsuit and actions that shareholders can take to safeguard their rights....

Continue Reading
Critical Insights on the Beyond Meat Securities Investigation

Updated Category News Views 241

Understanding the Investigation into Beyond Meat Beyond Meat, Inc. (NASDAQ: BYND), renowned for its innovative plant-based meat alternatives, is currently under scrutiny regarding potential violations of federal securities laws. This investigation, announced by a leading securities law firm, raises concerns for investors who may have suffered losses due to possible...

Continue Reading
Immunic Navigates Investor Events As Trials Advance

Updated Category News Views 2

Braving the Investor Circuit Immunic's ready to make some moves this July—this crew's diving headfirst into a trio of investor conferences. They're not just chitchatting; they’re taking one-on-one meetings, holding fireside chats. What’s the big draw? Their brainchild, vidofludimus calcium (IMU-838), which is knee-deep in phase 3 trials for relapsing multiple...

Continue Reading